Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

Expansion post phase 1? what expansion?

One pancreatic CA patient, treated with K mentioned 1/22/16 PR. 4 full cycles ,one month each, 3 wks treatment , one week off. In other words, very little treatment because K has such a short half life. Tumor size was stable "for more than 3 months"- I guess we should think then that tumor size then went up in that 4th month. No mention of CA 19-9 levels.

Question for the board: Which would you rather see- 1)we all sit around and wait for Mayo and Leo to get a grant(bound to be v competitive lots of applicants) OR 2) Dana Farber and BI find 3 or 4, or 5 or 6, or 10-12 pancreatic CA pts to get the new dosing decision 3x week, and get info on tumor size and CA19-9 in the very near term under whatever expanded phase protocol Leo has been talking about for a long time.

It is easy, of course, because CTIX could do both 1 and 2. That would be better for patients and better for shareholders- assuming that K actually has some measurable benefits

I say bring on the expansion, bring it on-